Crystal Lake, Illinois, October 22, 2026 -- AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced the ...
Developing biologics for pulmonary delivery starts with the molecule. Molecular structure, physicochemical properties and susceptibility to degradation can all influence stability, formulation ...
Submit your email address below and stay up to date with the latest industry insights.
In today’s regulatory environment, patient safety is a priority, making contamination control and sterility essential in pharmaceutical manufacturing. The latest EMA GMP Annex 1 revision recommends ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results